1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of FBLN1 mRNA CTD PMID:27840820 1,2-dimethylhydrazine multiple interactions ISO RGD:1318573 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBLN1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FBLN1 mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:1318572 6480464 Estradiol results in increased expression of FBLN1 mRNA CTD PMID:23019147 , PMID:25321415 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of FBLN1 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FBLN1 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FBLN1 mRNA CTD PMID:32741896 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318573 6480464 Tetrachlorodibenzodioxin affects the expression of FBLN1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FBLN1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318572 6480464 Tetrachlorodibenzodioxin affects the expression of FBLN1 mRNA CTD PMID:36370075 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FBLN1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FBLN1 mRNA CTD PMID:32109520 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1318573 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of FBLN1 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1318572 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBLN1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBLN1 mRNA CTD PMID:28628672 3-Nitrobenzanthrone decreases expression ISO RGD:1318572 6480464 3-nitrobenzanthrone results in decreased expression of FBLN1 mRNA CTD PMID:34036453 4,4'-sulfonyldiphenol increases expression ISO RGD:1318573 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FBLN1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FBLN1 mRNA CTD PMID:36041667 4-phenylbutyric acid increases expression ISO RGD:1318572 6480464 4-phenylbutyric acid results in increased expression of FBLN1 mRNA CTD PMID:14583596 5-azacytidine increases expression ISO RGD:1318572 6480464 Azacitidine results in increased expression of FBLN1 mRNA CTD PMID:21245298 5-fluorouracil affects expression ISO RGD:1318572 6480464 Fluorouracil affects the expression of FBLN1 mRNA CTD PMID:15205334 5-fluorouracil increases expression ISO RGD:1318572 6480464 Fluorouracil results in increased expression of FBLN1 mRNA CTD PMID:17039268 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FBLN1 mRNA CTD PMID:24780913 6alpha-methylprednisolone increases expression ISO RGD:1318572 6480464 Methylprednisolone results in increased expression of FBLN1 mRNA CTD PMID:19192274 8-Br-cAMP increases expression ISO RGD:1318572 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FBLN1 mRNA CTD PMID:15774544 acetamide increases expression EXP 6480464 acetamide results in increased expression of FBLN1 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of FBLN1 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1318572 6480464 Acrylamide results in decreased expression of FBLN1 mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of FBLN1 mRNA CTD PMID:23630614 , PMID:25378103 aflatoxin B1 increases expression ISO RGD:1318572 6480464 Aflatoxin B1 results in increased expression of FBLN1 mRNA CTD PMID:32234424 aflatoxin B1 affects methylation ISO RGD:1318572 6480464 Aflatoxin B1 affects the methylation of FBLN1 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1318573 6480464 Tretinoin results in increased expression of FBLN1 mRNA CTD PMID:16604517 amphotericin B increases expression ISO RGD:1318572 6480464 Amphotericin B analog results in increased expression of FBLN1 mRNA CTD PMID:28534445 arsenous acid increases expression ISO RGD:1318572 6480464 Arsenic Trioxide results in increased expression of FBLN1 mRNA CTD PMID:25555879 arsenous acid multiple interactions ISO RGD:1318572 6480464 [Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of FBLN1 mRNA CTD PMID:25555879 azathioprine increases expression ISO RGD:1318572 6480464 Azathioprine results in increased expression of FBLN1 mRNA CTD PMID:19192274 belinostat decreases expression ISO RGD:1318572 6480464 belinostat results in decreased expression of FBLN1 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:1318572 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBLN1 mRNA CTD PMID:27188386 benzo[a]pyrene multiple interactions ISO RGD:1318573 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to FBLN1 promoter] CTD PMID:19654925 benzo[a]pyrene increases expression ISO RGD:1318572 6480464 Benzo(a)pyrene results in increased expression of FBLN1 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1318573 6480464 Benzo(a)pyrene results in increased methylation of FBLN1 exon, Benzo(a)pyrene results in increased methylation of FBLN1 intron CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1318572 6480464 Benzo(a)pyrene results in decreased methylation of FBLN1 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1318572 6480464 Benzo(a)pyrene affects the methylation of FBLN1 intron CTD PMID:30157460 benzo[a]pyrene decreases expression ISO RGD:1318573 6480464 Benzo(a)pyrene results in decreased expression of FBLN1 mRNA CTD PMID:21569818 benzo[e]pyrene decreases methylation ISO RGD:1318572 6480464 benzo(e)pyrene results in decreased methylation of FBLN1 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1318572 6480464 Diethylhexyl Phthalate results in increased expression of FBLN1 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FBLN1 mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FBLN1 mRNA CTD PMID:36041667 bisphenol A decreases methylation ISO RGD:1318572 6480464 bisphenol A results in decreased methylation of FBLN1 gene CTD PMID:31601247 bisphenol A affects expression ISO RGD:1318572 6480464 bisphenol A affects the expression of FBLN1 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1318572 6480464 bisphenol A results in increased expression of FBLN1 mRNA CTD PMID:29275510 bisphenol A increases expression ISO RGD:1318573 6480464 bisphenol A results in increased expression of FBLN1 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:1318572 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FBLN1 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBLN1 mRNA CTD PMID:28628672 , PMID:31601247 bisphenol F multiple interactions ISO RGD:1318572 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBLN1 mRNA CTD PMID:28628672 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FBLN1 mRNA CTD PMID:36041667 bisphenol F increases expression ISO RGD:1318573 6480464 bisphenol F results in increased expression of FBLN1 mRNA CTD PMID:30951980 butan-1-ol multiple interactions ISO RGD:1318572 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FBLN1 mRNA CTD PMID:29432896 calcitriol decreases expression ISO RGD:1318572 6480464 Calcitriol results in decreased expression of FBLN1 mRNA CTD PMID:26485663 cantharidin decreases expression ISO RGD:1318573 6480464 Cantharidin results in decreased expression of FBLN1 mRNA CTD PMID:36907384 carbon nanotube affects expression ISO RGD:1318573 6480464 Nanotubes, Carbon affects the expression of FBLN1 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1318573 6480464 Nanotubes, Carbon analog results in decreased expression of FBLN1 mRNA CTD PMID:25554681 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of FBLN1 mRNA CTD PMID:18500788 chlormequat chloride increases expression EXP 6480464 Chlormequat results in increased expression of FBLN1 protein CTD PMID:34958886 chromium(6+) affects expression ISO RGD:1318573 6480464 chromium hexavalent ion affects the expression of FBLN1 mRNA CTD PMID:28472532 cobalt dichloride decreases secretion ISO RGD:1318572 6480464 cobaltous chloride results in decreased secretion of FBLN1 protein CTD PMID:22079246 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of FBLN1 mRNA CTD PMID:26033743 copper atom decreases expression EXP 6480464 Copper results in decreased expression of FBLN1 mRNA CTD PMID:30556269 copper atom multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 mRNA, [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 protein CTD PMID:22276220 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of FBLN1 mRNA CTD PMID:26033743 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of FBLN1 mRNA CTD PMID:30556269 copper(0) multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 mRNA, [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 protein CTD PMID:22276220 copper(II) sulfate decreases expression ISO RGD:1318572 6480464 Copper Sulfate results in decreased expression of FBLN1 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of FBLN1 mRNA CTD PMID:26577399 , PMID:27523638 cytarabine decreases expression ISO RGD:1318572 6480464 Cytarabine results in decreased expression of FBLN1 mRNA CTD PMID:21198554 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of FBLN1 mRNA CTD PMID:23640034 dexamethasone increases expression ISO RGD:1318573 6480464 Dexamethasone results in increased expression of FBLN1 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1318572 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBLN1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBLN1 mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1318572 6480464 Arsenic Trioxide results in increased expression of FBLN1 mRNA CTD PMID:25555879 diarsenic trioxide multiple interactions ISO RGD:1318572 6480464 [Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of FBLN1 mRNA CTD PMID:25555879 dibenz[a,h]anthracene increases expression ISO RGD:1318573 6480464 1 more ... CTD PMID:26377693 dioxygen multiple interactions ISO RGD:1318573 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of FBLN1 mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FBLN1 mRNA CTD PMID:33729688 diquat decreases expression ISO RGD:1318573 6480464 Diquat results in decreased expression of FBLN1 mRNA CTD PMID:36851058 diuron increases expression EXP 6480464 Diuron results in increased expression of FBLN1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1318572 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1318573 6480464 Doxorubicin results in increased expression of FBLN1 mRNA CTD PMID:15033991 doxorubicin decreases expression ISO RGD:1318572 6480464 Doxorubicin results in decreased expression of FBLN1 mRNA CTD PMID:29803840 doxorubicin affects expression ISO RGD:1318572 6480464 Doxorubicin affects the expression of FBLN1 mRNA CTD PMID:15205334 elemental selenium increases expression ISO RGD:1318572 6480464 Selenium results in increased expression of FBLN1 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FBLN1 mRNA CTD PMID:29391264 ethanol increases expression ISO RGD:1318573 6480464 Ethanol results in increased expression of FBLN1 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1318573 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBLN1 mRNA CTD PMID:22206623 fulvestrant increases methylation ISO RGD:1318572 6480464 Fulvestrant results in increased methylation of FBLN1 gene CTD PMID:31601247 fulvestrant multiple interactions ISO RGD:1318572 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FBLN1 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of FBLN1 mRNA CTD PMID:27387713 genistein increases expression ISO RGD:1318572 6480464 Genistein results in increased expression of FBLN1 mRNA CTD PMID:23019147 glycidyl methacrylate decreases expression ISO RGD:1318572 6480464 glycidyl methacrylate results in decreased expression of FBLN1 protein CTD PMID:36641056 hydrogen cyanide decreases expression ISO RGD:1318573 6480464 Hydrogen Cyanide results in decreased expression of FBLN1 mRNA CTD PMID:33914522 hydrogen peroxide affects expression ISO RGD:1318572 6480464 Hydrogen Peroxide affects the expression of FBLN1 mRNA CTD PMID:20044591 indometacin multiple interactions ISO RGD:1318572 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBLN1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBLN1 mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:1318573 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FBLN1 mRNA CTD PMID:36331819 isotretinoin increases expression ISO RGD:1318572 6480464 Isotretinoin results in increased expression of FBLN1 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1318572 6480464 Ivermectin results in decreased expression of FBLN1 protein CTD PMID:32959892 L-ascorbic acid increases expression ISO RGD:1318572 6480464 Ascorbic Acid results in increased expression of FBLN1 mRNA CTD PMID:25555879 L-ascorbic acid multiple interactions ISO RGD:1318572 6480464 [arsenic trioxide co-treated with Ascorbic Acid] results in increased expression of FBLN1 mRNA CTD PMID:25555879 medroxyprogesterone acetate increases expression ISO RGD:1318572 6480464 Medroxyprogesterone Acetate results in increased expression of FBLN1 mRNA, Medroxyprogesterone Acetate results in increased expression of FBLN1 protein CTD PMID:15774544 medroxyprogesterone acetate multiple interactions ISO RGD:1318572 6480464 Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of FBLN1 mRNA] CTD PMID:15774544 menadione affects expression ISO RGD:1318572 6480464 Vitamin K 3 affects the expression of FBLN1 mRNA CTD PMID:20044591 methapyrilene decreases methylation ISO RGD:1318572 6480464 Methapyrilene results in decreased methylation of FBLN1 intron CTD PMID:30157460 methotrexate increases expression ISO RGD:1318572 6480464 Methotrexate results in increased expression of FBLN1 mRNA CTD PMID:19192274 methylmercury chloride increases expression ISO RGD:1318572 6480464 methylmercuric chloride results in increased expression of FBLN1 mRNA CTD PMID:23179753 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of FBLN1 mRNA CTD PMID:34740672 mifepristone multiple interactions ISO RGD:1318572 6480464 Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of FBLN1 mRNA] CTD PMID:15774544 mifepristone decreases expression ISO RGD:1318572 6480464 Mifepristone results in decreased expression of FBLN1 mRNA CTD PMID:17584828 monosodium L-glutamate decreases expression ISO RGD:1318573 6480464 Sodium Glutamate results in decreased expression of FBLN1 mRNA CTD PMID:22078008 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] affects the methylation of FBLN1 gene CTD PMID:33148267 N-methyl-4-phenylpyridinium increases expression ISO RGD:1318573 6480464 1-Methyl-4-phenylpyridinium results in increased expression of FBLN1 protein CTD PMID:26558463 N-nitrosodiethylamine increases expression ISO RGD:1318573 6480464 Diethylnitrosamine results in increased expression of FBLN1 mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:1318573 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of FBLN1 mRNA] CTD PMID:17854601 ozone multiple interactions ISO RGD:1318573 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FBLN1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FBLN1 mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:1318573 6480464 Acetaminophen affects the expression of FBLN1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FBLN1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1318572 6480464 Acetaminophen results in increased expression of FBLN1 mRNA CTD PMID:22230336 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 pentane-2,3-dione decreases expression EXP 6480464 2, 3-pentanedione results in decreased expression of FBLN1 mRNA CTD PMID:25710175 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1318573 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FBLN1 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:1318573 6480464 perfluorooctanoic acid results in increased expression of FBLN1 protein CTD PMID:36214631 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] affects the methylation of FBLN1 gene CTD PMID:33148267 phenobarbital multiple interactions ISO RGD:1318573 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FBLN1 mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:1318573 6480464 Phenobarbital results in increased expression of FBLN1 mRNA CTD PMID:19482888 phenylmercury acetate decreases expression ISO RGD:1318572 6480464 Phenylmercuric Acetate results in decreased expression of FBLN1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1318572 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBLN1 mRNA CTD PMID:27188386 pioglitazone increases expression ISO RGD:1318572 6480464 Pioglitazone results in increased expression of FBLN1 mRNA CTD PMID:30031879 pirinixic acid decreases expression ISO RGD:1318573 6480464 pirinixic acid results in decreased expression of FBLN1 mRNA CTD PMID:17426115 potassium chromate decreases expression ISO RGD:1318572 6480464 potassium chromate(VI) results in decreased expression of FBLN1 mRNA CTD PMID:22714537 potassium cyanide increases expression ISO RGD:1318573 6480464 Potassium Cyanide results in increased expression of FBLN1 mRNA CTD PMID:33914522 potassium dichromate increases expression ISO RGD:1318573 6480464 Potassium Dichromate results in increased expression of FBLN1 mRNA CTD PMID:23608068 potassium dichromate increases expression ISO RGD:1318572 6480464 Potassium Dichromate results in increased expression of FBLN1 protein CTD PMID:23718831 prednisolone increases expression ISO RGD:1318572 6480464 Prednisolone results in increased expression of FBLN1 mRNA CTD PMID:19192274 progesterone increases expression ISO RGD:1318572 6480464 Progesterone results in increased expression of FBLN1 mRNA CTD PMID:15774544 sarin decreases expression ISO RGD:1318572 6480464 Sarin results in decreased expression of FBLN1 mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:1318572 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:1318572 6480464 Selenium results in increased expression of FBLN1 mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO RGD:1318572 6480464 Silicon Dioxide analog results in decreased expression of FBLN1 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1318572 6480464 Silicon Dioxide analog results in increased expression of FBLN1 mRNA CTD PMID:23806026 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of FBLN1 mRNA CTD PMID:21865292 sodium arsenite decreases expression ISO RGD:1318572 6480464 sodium arsenite results in decreased expression of FBLN1 mRNA CTD PMID:22714537 sodium arsenite decreases methylation ISO RGD:1318572 6480464 sodium arsenite results in decreased methylation of FBLN1 intron CTD PMID:32844245 sodium arsenite increases expression ISO RGD:1318572 6480464 sodium arsenite results in increased expression of FBLN1 mRNA CTD PMID:29301061 , PMID:32844245 sodium arsenite decreases expression ISO RGD:1318573 6480464 sodium arsenite results in decreased expression of FBLN1 mRNA CTD PMID:18812580 sodium aurothiomalate increases expression ISO RGD:1318572 6480464 Gold Sodium Thiomalate results in increased expression of FBLN1 mRNA CTD PMID:19192274 Soman increases expression EXP 6480464 Soman results in increased expression of FBLN1 mRNA CTD PMID:19281266 sulforaphane multiple interactions ISO RGD:1318573 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of FBLN1 mRNA CTD PMID:30529165 sunitinib decreases expression ISO RGD:1318572 6480464 Sunitinib results in decreased expression of FBLN1 mRNA CTD PMID:31533062 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of FBLN1 mRNA CTD PMID:21865292 temozolomide increases expression ISO RGD:1318572 6480464 Temozolomide results in increased expression of FBLN1 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:1318572 6480464 tert-Butylhydroperoxide results in decreased expression of FBLN1 mRNA CTD PMID:15336504 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FBLN1 mRNA CTD PMID:32741896 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FBLN1 mRNA CTD PMID:31150632 tetrathiomolybdate(2-) multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 mRNA, [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 protein CTD PMID:22276220 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FBLN1 mRNA CTD PMID:23411599 titanium dioxide decreases expression ISO RGD:1318573 6480464 titanium dioxide results in decreased expression of FBLN1 mRNA CTD PMID:23557971 , PMID:27760801 trichloroethene decreases expression ISO RGD:1318573 6480464 Trichloroethylene results in decreased expression of FBLN1 mRNA CTD PMID:25549359 trichostatin A multiple interactions ISO RGD:1318572 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBLN1 mRNA CTD PMID:27188386 trichostatin A increases expression ISO RGD:1318572 6480464 trichostatin A results in increased expression of FBLN1 mRNA CTD PMID:24935251 more ... triclosan increases expression ISO RGD:1318572 6480464 Triclosan results in increased expression of FBLN1 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:1318573 6480464 trimellitic anhydride results in decreased expression of FBLN1 mRNA CTD PMID:19042947 tunicamycin decreases expression ISO RGD:1318572 6480464 Tunicamycin results in decreased expression of FBLN1 mRNA CTD PMID:22378314 valproic acid decreases expression ISO RGD:1318572 6480464 Valproic Acid results in decreased expression of FBLN1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1318572 6480464 Valproic Acid affects the expression of FBLN1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1318573 6480464 Valproic Acid results in increased expression of FBLN1 mRNA CTD PMID:24896083 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of FBLN1 mRNA CTD PMID:23034163 vitamin E increases expression ISO RGD:1318572 6480464 Vitamin E results in increased expression of FBLN1 mRNA CTD PMID:19244175 vorinostat multiple interactions ISO RGD:1318572 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBLN1 mRNA CTD PMID:27188386 zoledronic acid increases expression ISO RGD:1318572 6480464 zoledronic acid results in increased expression of FBLN1 mRNA, zoledronic acid results in increased expression of FBLN1 protein CTD PMID:24714768 , PMID:28871336